Department of Oncology, Technical University of Munich, 81675 Munich, Germany
Mini Review
Hsa-miR-665 Holds Promise as a Biomarker for Prognostic Assessment in Cancer
Author(s): John Scott*
Hsa-miR-665, a microRNA molecule, has emerged as a promising biomarker with significant potential in the realm of cancer prognosis. This review
explores the landscape of Hsa-miR-665 and its role as a prognostic indicator in various cancer types. By examining the latest research findings and
its implications, this review underscores the significance of Hsa-miR-665 as a biomarker in predicting disease outcomes, aiding clinical decisionmaking
and advancing personalized cancer care... Read More»
DOI:
10.37421/2155-9929.2023.14.601
Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report